MARK AGUSTIN: Open Payments
NPI 1730855677 · EVANSTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $142 |
| United Therapeutics Corporation | 1 | $128 |
| AstraZeneca Pharmaceuticals LP | 1 | $97 |
| Viatris Specialty LLC | 1 | $59 |
| GlaxoSmithKline, LLC. | 1 | $43 |
Products named: DUPIXENT, FASENRA, YUPELRI.
Industry payments across IL — which companies pay providers there.
